Earnings calls

Senores Pharma. concall ledger

Every earnings call for SENORES — management tone, guidance, KPIs and promise tracking, quarter by quarter.

SENORES · 2 transcripts · Healthcare · latest Q3 FY26

Q3 FY26Published 20 Jan 2026Call held 20 Jan 2026

SENORES Q3 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹175 cr+64% YoYConsolidated EBITDA₹54 cr+86% YoYConsolidated EBITDA Margin30.9%Consolidated PAT₹32 cr+85% YoY

Consolidated Revenue ₹175 cr (+64% YoY); Consolidated EBITDA ₹54 cr (+86% YoY); Consolidated EBITDA Margin 30.9%. Consolidated revenue grew 64% YoY to INR175 crores in Q3 FY26.

Read full transcript & analysis

Q1 FY26Published 24 Jul 2025Call held 24 Jul 2025

SENORES Q1 FY26 Earnings Call Transcript & Analysis

Revenue₹138 cr+72% YoYEBITDA₹34 cr+60% YoYEBITDA Margin24.8%−2% YoYPAT₹21 cr+95% YoY

Revenue ₹138 cr (+72% YoY); EBITDA ₹34 cr (+60% YoY); EBITDA Margin 24.8% (−2% YoY). Consolidated revenue grew by 72% YoY to INR 138 crores.

Read full transcript & analysis